279 related articles for article (PubMed ID: 34566848)
1. Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.
Wang W; Wei CJ; Cui XW; Li YH; Gu YH; Gu B; Li QF; Wang ZC
Front Neurol; 2021; 12():704639. PubMed ID: 34566848
[TBL] [Abstract][Full Text] [Related]
2. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
3. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
4. Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
Kaufmann D; Müller R; Bartelt B; Wolf M; Kunzi-Rapp K; Hanemann CO; Fahsold R; Hein C; Vogel W; Assum G
Am J Hum Genet; 2001 Dec; 69(6):1395-400. PubMed ID: 11704931
[TBL] [Abstract][Full Text] [Related]
5. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
6. Piebaldism Associated with Café-au-lait Macules and Intertriginous Freckling: A Case Report and Review of the Literature.
Akarsu S; İlknur T; Avcı C; Fetil E
Ann Dermatol; 2019 Oct; 31(5):567-570. PubMed ID: 33911651
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Findings in Neurofibromatosis Type 1.
Ozarslan B; Russo T; Argenziano G; Santoro C; Piccolo V
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530415
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
9. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene.
Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J
Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentation and Novel Pathogenic Variants among 68 Chinese Neurofibromatosis 1 Children.
Yao R; Yu T; Xu Y; Yu L; Wang J; Wang X; Wang J; Shen Y
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31717729
[TBL] [Abstract][Full Text] [Related]
12. Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes.
Sharafi P; Ayter S
J Neurogenet; 2018; 32(2):65-77. PubMed ID: 29644913
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1.
Anderson JL; Gutmann DH
Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
[TBL] [Abstract][Full Text] [Related]
14. A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report.
Santoro C; Giugliano T; Bernardo P; Palladino F; Torella A; Del Vecchio Blanco F; Onore ME; Carotenuto M; Nigro V; Piluso G
BMC Neurol; 2020 Sep; 20(1):327. PubMed ID: 32873259
[TBL] [Abstract][Full Text] [Related]
15. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
16. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
17. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.
Sung H; Hyland PL; Pemov A; Sabourin JA; Baldwin AM; Bass S; Teshome K; Luo W; ; Widemann BC; Stewart DR; Wilson AF
Mol Genet Genomic Med; 2020 Oct; 8(10):e1400. PubMed ID: 32869517
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
